Core Laboratories Inc.
CLB
$12.26
-$0.36-2.85%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.16M | 21.47M | 17.70M | 14.91M | 15.12M |
| Total Receivables | 127.36M | 132.38M | 130.73M | 129.54M | 123.07M |
| Inventory | 59.40M | 65.49M | 69.90M | 70.71M | 71.70M |
| Prepaid Expenses | 10.18M | 9.72M | 9.86M | 9.56M | 8.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 10.52M | 6.17M | 5.34M | 4.33M | 5.09M |
| Total Current Assets | 226.61M | 235.23M | 233.53M | 229.05M | 223.14M |
|
|
|||||
| Total Current Assets | 226.61M | 235.23M | 233.53M | 229.05M | 223.14M |
| Net Property, Plant & Equipment | 153.55M | 154.26M | 154.20M | 152.16M | 153.47M |
| Long-term Investments | 99.45M | 99.45M | 99.45M | 99.45M | 99.45M |
| Goodwill | 99.45M | 99.45M | 99.45M | 99.45M | 99.45M |
| Total Other Intangibles | 6.40M | 6.55M | 6.67M | 6.80M | 6.93M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 99.32M | 104.99M | 103.95M | 100.50M | 98.58M |
| Total Assets | 590.41M | 600.47M | 597.80M | 587.95M | 586.40M |
|
|
|||||
| Total Accounts Payable | 34.55M | 33.63M | 36.86M | 32.49M | 33.51M |
| Total Accrued Expenses | 30.01M | 28.08M | 26.93M | 24.33M | 24.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.69M | 11.44M | 11.05M | 10.43M | 10.18M |
| Total Finance Division Other Current Liabilities | 22.34M | 21.80M | 22.76M | 18.23M | 19.69M |
| Total Other Current Liabilities | 22.34M | 21.80M | 22.76M | 18.23M | 19.69M |
| Total Current Liabilities | 97.59M | 94.94M | 97.60M | 85.47M | 88.10M |
|
|
|||||
| Total Current Liabilities | 97.59M | 94.94M | 97.60M | 85.47M | 88.10M |
| Long-Term Debt | 126.11M | 139.87M | 147.62M | 160.37M | 163.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.34M | 43.73M | 42.62M | 41.48M | 42.08M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 65.63M | 65.51M | 64.27M | 63.21M | 63.28M |
| Total Liabilities | 332.67M | 344.05M | 352.11M | 350.53M | 356.59M |
|
|
|||||
| Common Stock & APIC | 110.02M | 113.08M | 113.95M | 115.11M | 110.48M |
| Retained Earnings | 150.28M | 143.35M | 132.07M | 123.51M | 120.76M |
| Treasury Stock & Other | -8.31M | -5.68M | -5.74M | -6.46M | -6.42M |
| Total Common Equity | 251.99M | 250.74M | 240.27M | 232.16M | 224.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 251.99M | 250.74M | 240.27M | 232.16M | 224.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 5.75M | 5.68M | 5.42M | 5.26M | 4.99M |
| Total Equity | 257.74M | 256.42M | 245.69M | 237.42M | 229.81M |
|
|
|||||